Simple and rapid HPLC method for simultaneous determination of atenolol and chlorthalidone in spiked human plasma

Saudi Pharmaceutical Journal

Volumn 19, Issue 1, 2011, Pages 43-49

  Elgawish, Mohamed S ^a   Mostafa, Samia M ^a   Elshanawane, Abdalla A ^b  

^a Suez Canal University   (Egypt)

^b Zagazig University   (Egypt)

Author keywords

Atenolol; Chlorthalidone; Column liquid chromatography; Human plasma

Indexed keywords

ACETONITRILE; ATENOLOL; CHLORTALIDONE; HYDROCHLOROTHIAZIDE; METHANOL;

ACCURACY; ARTICLE; DRUG DETERMINATION; FLOW RATE; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PLASMA; PRECIPITATION; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STANDARD; TEMPERATURE; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 78650622373     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2010.10.003     Document Type: Article

References (29)

1. Dadgar D., Kelly M.T. Determination of chlorthalidone in human plasma by reversed-phase micellar liquid chromatography. Analyst 1988, 113:113-117.
2. Degen E.H., Schweizer A. Quantitative determination of drugs in biological materials by means of extractive alkylation and gas-liquid chromatography. J. Chromatogr. 1977, 142:549-557.
3. Dong L.L., Huang J.X. Determination of atenolol in human plasma by pseudo reversed phase liquid chromatography-tandem mass spectrometry. Chromatographia 2006, 64:583-586.
4. Dupuis C., Gaulier J.M., Pelissier-Alicot A.L., Marquet P., Lachatre G. Determination of three beta-blockers in biofluids and solid tissues by liquid chromatography-electrospray-mass spectrometry. J. Anal. Toxicol. 2004, 28:674-679.
5. El-Gindy A., Emara S., Mostafa A. HPLC and chemometric-assisted spectrophotometric methods for simultaneous determination of atenolol, amiloride hydrochloride and chlorthalidone. Farmaco 2005, 60:269-278.
6. El-Gindy A., Sallam S., Abdel-salam R. HPLC method for the simultaneous determination of atenolol and chlorthalidone in human breast milk. J. Sep. Sci. 2008, 31:677-682.
7. Elshanawane A.A., Mostafa S.M., Elgawish M.S. Development and validation of a reversed-phase high-performance liquid chromatographic method for the simultaneous determination of amiloride hydrochloride, atenolol, hydrochlorothiazide, and chlorthalidone in their combined mixtures. J. AOAC Int. 2009, 92:404-409.
8. Ervik M., Gustavii K. Application of the extractive alkylation technique to the gas chromatographic determination of chlorthalidone in plasma in nanogram quantities. Anal. Chem. 1974, 46:39-42.
9. Ferraro M.C., Castellano P.M., Kaufman T.S. Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms. Anal. Bioanal. Chem. 2003, 377:1159-1164.
10. Giachetti C., Tenconi A., Canali S., Zanolo G. Simultaneous determination of atenolol and chlorthalidone in plasma by high-performance liquid chromatography. Application to pharmacokinetic studies in man. J. Chromatogr. B 1997, 698:187-194.
11. Goebel C., Trout G.J., Kazlauskas R. Rapid screening method for diuretics in doping control using automated solid phase extraction and liquid chromatography-electrospray tandem mass spectrometry. Anal. Chim. Acta 2004, 502:65-74.
12. Guadrado A., Gascon A.R., Hernandez R.M., Castilla A.M., de la Maza A., de Ocariz A.L., Calvo B., Pedraz J.L. In vitro and in vivo equivalence of two oral atenolol tablet formulations. Arzneimittel-Forschung Drug Res. 2002, 52:371-378.
13. Johnson R.D., Lewis R.J. Quantitation of atenolol, metoprolol, and propranolol in postmortem human fluid and tissue specimens via LC/APCI-MS. Forensic Sci. Int. 2006, 156:106-117.
14. Malluca J.O., Monson K. New and expedient determination of atenolol in biological samples. J. Pharm. Sci. 1975, 64:1992-1994.
15. Martins M.L., Pierossi M.A., Moraes L.A., Ribeiro W., Abbib E., Mendes G.B., Poli A., DeNucci G., Muscara M.N. Comparative bioavailability of two atenolol tablet formulation in healthy male volunteers after a single dose administration. Int. J. Clin. Pharmacol. Ther. 1997, 35:324-328.
16. Moffat A.C., Osselton M.D., Widdop B., Galichet L.Y. Clarke's Analysis of Drug and Poisons in Pharmaceutical, Body Fluids and Postmortem Material 2004, Pharmaceutical Press, London/Chicago.
17. Mohamed A., Salem H. Determination of antihypertensive mixtures by use of a chemometrics-assisted spectrophotometric method. Anal. Bioanal. Chem. 2005, 382:1066-1072.
18. Muirhead D.C., Christie R.B. Simple, sensitive and selective high-performance liquid chromatographic method for analysis of chlorthalidone in whole blood. J. Chromatogr. 1987, 416:420-425.
19. Niopas I., Daftsios A.C., Xanthakis I., Nikolaidis N., Njau S.N. Bioequivalence of two tablet formulations of atenolol after single oral administration in healthy volunteers. Arzneimittel-Forschung Drug Res. 2000, 50:E243-E247.
20. Prichard B.N., Cruickshank J.M., Graham B.R. Beta-adrenergic blocking drugs in the treatment of hypertension. Blood Pressure 2001, 10:366-386.
21. Ranta V.P., Toropainen E., Talvitie A., Auriola S., Urtti A. Simultaneous determination of eight beta-blockers by gradient high performance liquid chromatography with combined ultraviolet and fluorescence detection in corneal permeability studies in vitro. J. Chromatogr. B 2002, 772:81-87.
22. Sweetman S.C. Martindale - The Complete Drug Reference 2006, Pharmaceutical Press, London. 37th ed.
23. Thomson A.E. Chlorthalidone in the long term therapy of patients with hypertension. Int. J. Clin. Pharmacol. Ther. 1970, 3:21-25.
24. The United States Pharmacopoeia 30, The National Formulary 25, 2007. United States Pharmacopoeial Convention, INC.
25. US Department of Health and Human Services, 2001. Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. Center for Drug Evaluation and Research, Rockville, MD.
26. Wadworth A.N., Murdoch D., Brogden R.N. Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 1991, 42:468-510.
27. Wan S.H., Maronde R.F., Matin S.B. GLC determination of atenolol and beta-blocking agents in biological fluids. J. Pharm. Sci. 1978, 67:1340-1342.
28. Wu F.L.L., Chen P.F., Lee Y.J., Chen R.R.L. Comparative pharmacokinetics of two atenolol products. J. Food Drug Anal. 2003, 11:4-7.
29. Yu S.X., Li S., Yang H., Lee F., Wu J.T., Qian M.G. Tandem mass spectrometry with online high-flow reversed-phase extraction and normal-phase chromatography on silica columns with aqueous-organic mobile phase for quantitation of polar compounds in biological fluids. Rapid Commun. Mass Spectrom. 2005, 19:250-254.